Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Pediatrix Medical Group Inc shares valued at $515,430 were sold by ORDAN MARK S on Dec 15 ’25. At $22.41 per share, ORDAN MARK S sold 23,000 shares. The insider’s holdings dropped to 302,805 shares worth approximately $6.67 million following the completion of this transaction.
Also, ORDAN MARK S purchased 23,000 shares, netting a total of over 517,500 in proceeds.
Before that, Rucker Michael A. had sold 10,478 shares from its account. In a trade valued at $240,994, the Director traded Pediatrix Medical Group Inc shares for $23.00 each. Upon closing the transaction, the insider’s holdings decreased to 10,478 shares, worth approximately $1.3 million.
As published in their initiating research note from Macquarie on December 16, 2024, Pediatrix Medical Group Inc [MD] has been an Outperform. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late September. As of June 07, 2024, Deutsche Bank has increased its “Sell” rating to a “Hold” for MD. Earlier on September 27, 2021, SVB Leerink initiated its rating. Their recommendation was “a Mkt perform” for MD stock.
Analyzing MD Stock Performance
On last trading session, Pediatrix Medical Group Inc [NYSE: MD] plunged -0.68% to $22.02. The stock’s lowest price that day was $21.67, but it reached a high of $22.295 in the same session. During the last five days, there has been a surge of approximately 0.41%. Over the course of the year, Pediatrix Medical Group Inc shares have jumped approximately 65.44%.
Is Pediatrix Medical Group Inc subject to short interest?
Stocks of Pediatrix Medical Group Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.13 million shares to 3.04 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 3.16 million shares. A decline of -4.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.24 of the overall float, the days-to-cover ratio (short ratio) decline to 3.24.
Which companies own the most shares of Pediatrix Medical Group Inc (MD)?
In terms of Pediatrix Medical Group Inc share price expectations, FactSet research, analysts set an average price target of 23.5 in the next 12 months, up nearly 6.0% from the previous closing price of $22.17. Analysts anticipate Pediatrix Medical Group Inc stock to reach 24 by 2026, with the lowest price target being 23. In spite of this, 3 analysts ranked Pediatrix Medical Group Inc stock as Hold at the end of 2026. On June 23, 2021, Stifel assigned a price target of “a Hold” to the stock and resumed coverage with a $30.
